Header Logo

Majaz Moonis

Concepts (316)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Stroke
26
2020
1127
3.370
Why?
Brain Ischemia
15
2020
399
2.690
Why?
Leukoaraiosis
6
2019
44
1.280
Why?
Thrombolytic Therapy
8
2020
184
1.270
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
5
2012
204
0.870
Why?
Purpura, Thrombotic Thrombocytopenic
1
2022
8
0.780
Why?
Tissue Plasminogen Activator
5
2020
125
0.750
Why?
Fibrinolytic Agents
3
2020
163
0.660
Why?
Amyloid beta-Peptides
3
2015
286
0.660
Why?
Quality of Health Care
2
2014
513
0.640
Why?
Sleep
2
2015
215
0.620
Why?
Atrial Fibrillation
4
2020
805
0.600
Why?
Amnesia
2
2015
9
0.580
Why?
Anticoagulants
4
2019
480
0.580
Why?
Cerebral Infarction
3
2015
76
0.480
Why?
Health Status Disparities
1
2016
137
0.470
Why?
Humans
57
2024
59366
0.460
Why?
Heparin, Low-Molecular-Weight
2
2006
26
0.450
Why?
Platelet Aggregation Inhibitors
2
2007
211
0.440
Why?
Heparin
2
2006
111
0.430
Why?
Blood Pressure
1
2015
495
0.420
Why?
Aspergillosis
4
1994
40
0.410
Why?
Aged
26
2020
13405
0.390
Why?
Neuroimaging
2
2014
143
0.380
Why?
Arterial Occlusive Diseases
1
2012
71
0.380
Why?
Cognitive Dysfunction
1
2015
309
0.370
Why?
Male
36
2020
27742
0.370
Why?
Sex Characteristics
1
2012
197
0.360
Why?
Ischemic Attack, Transient
2
2019
90
0.350
Why?
Severity of Illness Index
8
2019
1479
0.350
Why?
Hypoglossal Nerve Diseases
1
2009
2
0.340
Why?
Dysarthria
1
2009
7
0.340
Why?
Internal Capsule
1
2009
11
0.340
Why?
Middle Aged
23
2020
16310
0.340
Why?
Tongue
1
2009
15
0.330
Why?
Movement Disorders
1
2009
22
0.330
Why?
Acute Disease
6
2009
658
0.330
Why?
Hospitalization
1
2016
1290
0.310
Why?
Female
30
2020
30719
0.310
Why?
Aspirin
2
2007
167
0.310
Why?
Telemedicine
2
2014
307
0.310
Why?
Heart Failure
1
2016
853
0.300
Why?
Hypertension
3
2016
568
0.300
Why?
Predictive Value of Tests
6
2020
1027
0.300
Why?
Magnetic Resonance Imaging
7
2024
2052
0.300
Why?
Tomography, X-Ray Computed
6
2014
1507
0.290
Why?
Aged, 80 and over
12
2020
5119
0.280
Why?
Alzheimer Disease
5
2009
679
0.270
Why?
Coronary Angiography
1
2007
176
0.270
Why?
White Matter
2
2019
114
0.270
Why?
Brain
4
2017
1488
0.260
Why?
Cerebrovascular Circulation
2
2012
174
0.260
Why?
Risk Factors
8
2020
4986
0.260
Why?
Diagnosis, Computer-Assisted
1
2006
42
0.260
Why?
Polysomnography
1
2006
55
0.250
Why?
Cardiac Catheterization
1
2007
253
0.250
Why?
Cerebral Hemorrhage
5
2017
85
0.250
Why?
Cognition Disorders
2
2005
215
0.250
Why?
Sleep Wake Disorders
1
2006
65
0.240
Why?
Encephalomyelitis, Eastern Equine
1
2024
2
0.240
Why?
Treatment Outcome
10
2020
5281
0.230
Why?
Retrospective Studies
12
2024
6069
0.230
Why?
Peptide Fragments
2
2007
400
0.230
Why?
HIV-1
5
2001
692
0.220
Why?
Presenilin-1
4
2009
57
0.220
Why?
Ticlopidine
1
2003
45
0.210
Why?
Injections, Intravenous
4
2009
155
0.210
Why?
Antihypertensive Agents
1
2004
162
0.210
Why?
Disintegrins
1
2022
4
0.200
Why?
ADAMTS13 Protein
1
2022
6
0.200
Why?
Thrombospondins
1
2022
6
0.200
Why?
Antifungal Agents
2
1993
120
0.190
Why?
Cholesterol
3
2009
252
0.190
Why?
Receptors, CXCR4
1
2001
34
0.190
Why?
Th2 Cells
1
2001
99
0.190
Why?
Receptors, CCR5
1
2001
56
0.190
Why?
Models, Biological
1
2006
1143
0.180
Why?
Algorithms
1
2006
974
0.180
Why?
Incidence
2
2019
1238
0.180
Why?
Th1 Cells
1
2001
177
0.180
Why?
Hematoma
2
2019
68
0.170
Why?
Time Factors
6
2019
3615
0.170
Why?
Bed Rest
1
2019
10
0.170
Why?
Vitamin K
1
2019
14
0.160
Why?
Secondary Prevention
3
2006
151
0.160
Why?
Intracranial Hemorrhages
1
2019
61
0.160
Why?
Mechanical Thrombolysis
1
2019
35
0.160
Why?
Leukoencephalopathies
1
2019
24
0.150
Why?
Heterozygote
3
2009
161
0.150
Why?
Dementia
2
2003
248
0.150
Why?
Neuropsychological Tests
2
1996
371
0.140
Why?
Prevalence
3
2020
1253
0.140
Why?
Recombinant Proteins
3
2020
689
0.130
Why?
Occipital Lobe
1
1996
17
0.130
Why?
Eligibility Determination
1
2016
35
0.130
Why?
India
2
2014
150
0.130
Why?
California
1
2016
161
0.130
Why?
Meningeal Neoplasms
1
1996
58
0.130
Why?
Cerebrum
1
2015
16
0.130
Why?
Time-to-Treatment
1
2016
98
0.120
Why?
Glioblastoma
2
1998
155
0.120
Why?
Endovascular Procedures
3
2017
608
0.120
Why?
National Institutes of Health (U.S.)
1
2015
111
0.120
Why?
Survival Analysis
2
2007
554
0.120
Why?
Clodronic Acid
1
1994
4
0.110
Why?
Amphotericin B
1
1994
21
0.110
Why?
Risk Assessment
4
2020
1925
0.110
Why?
Phagocytes
1
1994
50
0.110
Why?
Brain Neoplasms
2
1998
305
0.110
Why?
Patient Selection
1
2016
465
0.110
Why?
Multivariate Analysis
3
2017
902
0.110
Why?
Prognosis
3
2009
1597
0.110
Why?
Length of Stay
1
2017
776
0.110
Why?
Lethal Dose 50
4
1994
14
0.110
Why?
Phosphatidic Acids
1
1993
7
0.110
Why?
Infarction, Middle Cerebral Artery
1
2014
70
0.100
Why?
Recurrence
2
2005
602
0.100
Why?
Mannose
1
1993
21
0.100
Why?
Cognition
1
1996
454
0.100
Why?
Aspergillus fumigatus
1
1993
52
0.100
Why?
Liposomes
4
1994
100
0.100
Why?
Diffusion Magnetic Resonance Imaging
2
2020
145
0.100
Why?
Tetanus
1
1991
5
0.100
Why?
Mutation
4
2009
2456
0.090
Why?
Diagnosis, Differential
3
2019
931
0.090
Why?
Spinal Cord Compression
1
1991
28
0.090
Why?
Macrophage Activation
1
1992
118
0.090
Why?
Diabetes Mellitus
1
2016
515
0.090
Why?
Cohort Studies
2
2019
2375
0.090
Why?
Mice, Inbred BALB C
4
1994
868
0.090
Why?
Follow-Up Studies
2
2007
2338
0.090
Why?
Phagocytosis
1
1992
260
0.090
Why?
Randomized Controlled Trials as Topic
2
2004
677
0.090
Why?
Delivery of Health Care
1
2014
411
0.090
Why?
Efferent Pathways
1
2009
13
0.080
Why?
Transcranial Magnetic Stimulation
1
2009
26
0.080
Why?
Edema
1
1989
42
0.080
Why?
Peripheral Nerves
1
1989
30
0.080
Why?
Sensitivity and Specificity
2
2017
1091
0.080
Why?
Adult
9
2019
15679
0.080
Why?
Patient Education as Topic
1
2013
453
0.080
Why?
Macrophages
2
1993
1015
0.080
Why?
Eye
1
1989
52
0.080
Why?
Hand
1
2009
67
0.080
Why?
Regression Analysis
2
2014
486
0.080
Why?
Injections, Intra-Arterial
1
2009
20
0.080
Why?
Odds Ratio
2
2016
747
0.080
Why?
Plant Oils
1
1989
56
0.080
Why?
Emergency Service, Hospital
1
2017
1022
0.080
Why?
Polyenes
3
1993
4
0.080
Why?
Muscles
1
1989
173
0.080
Why?
Hyperparathyroidism
1
1988
7
0.080
Why?
Virus Replication
3
2001
305
0.080
Why?
Reproducibility of Results
2
2019
1559
0.080
Why?
Thalamic Diseases
1
1988
2
0.070
Why?
Clinical Competence
1
2013
682
0.070
Why?
Antiviral Agents
3
1996
313
0.070
Why?
Muscular Diseases
1
1988
46
0.070
Why?
Tissue Distribution
3
1993
287
0.070
Why?
Electroencephalography
2
2024
134
0.070
Why?
Animals
8
2005
19649
0.070
Why?
Platelet Function Tests
1
2007
10
0.070
Why?
Cyclooxygenase 1
1
2007
18
0.070
Why?
Thromboxane A2
1
2007
5
0.070
Why?
Platelet Activation
1
2007
26
0.070
Why?
Disease Progression
2
2017
1119
0.070
Why?
Amyloid beta-Protein Precursor
1
2007
77
0.070
Why?
Drug Resistance
1
2007
95
0.070
Why?
Pedigree
1
2007
183
0.070
Why?
Radiopharmaceuticals
1
2007
180
0.070
Why?
Amyloid
1
2007
65
0.070
Why?
Corpus Striatum
1
2007
93
0.070
Why?
Drug Administration Schedule
2
2004
284
0.070
Why?
Pattern Recognition, Automated
1
2006
51
0.070
Why?
Intracranial Thrombosis
1
2006
27
0.060
Why?
Information Storage and Retrieval
1
2006
60
0.060
Why?
Cerebral Angiography
2
2014
280
0.060
Why?
Cluster Analysis
1
2006
245
0.060
Why?
Ischemia
1
2007
199
0.060
Why?
Enzyme Inhibitors
1
2007
347
0.060
Why?
Drug Combinations
2
2003
147
0.060
Why?
Data Interpretation, Statistical
1
2006
191
0.060
Why?
Streptokinase
1
2005
6
0.060
Why?
Thrombosis
1
2007
182
0.060
Why?
Drug Therapy, Combination
2
2005
451
0.060
Why?
Expert Testimony
1
2005
17
0.060
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2005
23
0.060
Why?
Encephalitis Virus, Eastern Equine
1
2024
1
0.060
Why?
Family Health
1
2005
67
0.060
Why?
Recovery of Function
2
2019
270
0.060
Why?
Heart Diseases
1
2007
206
0.060
Why?
Venous Thrombosis
1
2006
110
0.060
Why?
DNA Mutational Analysis
1
2005
188
0.060
Why?
Meta-Analysis as Topic
1
2005
77
0.060
Why?
Models, Statistical
1
2006
298
0.060
Why?
Cerebrovascular Disorders
1
2005
74
0.060
Why?
Coronary Artery Disease
1
2007
274
0.060
Why?
Genetic Testing
1
2005
126
0.060
Why?
Neuroprotective Agents
1
2005
72
0.060
Why?
Risk
1
2005
364
0.060
Why?
Anticonvulsants
1
2024
88
0.060
Why?
Down-Regulation
1
2005
305
0.060
Why?
tau Proteins
1
2005
191
0.060
Why?
Aspirin, Dipyridamole Drug Combination
1
2003
3
0.060
Why?
Dipyridamole
1
2003
17
0.060
Why?
Artificial Intelligence
1
2006
154
0.050
Why?
Computer Simulation
1
2006
458
0.050
Why?
Primary Prevention
1
2004
134
0.050
Why?
Diagnostic Errors
2
1996
94
0.050
Why?
Logistic Models
2
2017
1235
0.050
Why?
Databases, Factual
1
2006
814
0.050
Why?
Dose-Response Relationship, Drug
1
2004
805
0.050
Why?
Health Services
1
2003
81
0.050
Why?
Chromatography, High Pressure Liquid
2
1993
225
0.050
Why?
Chemokines, CC
1
2001
30
0.050
Why?
Genetic Predisposition to Disease
1
2005
676
0.050
Why?
Cell Polarity
1
2001
110
0.050
Why?
Drug Carriers
2
1993
175
0.040
Why?
DNA, Viral
1
2001
223
0.040
Why?
HIV Infections
2
2000
913
0.040
Why?
Electromyography
2
1991
88
0.040
Why?
Infusions, Intravenous
1
2020
163
0.040
Why?
Membrane Proteins
1
2005
850
0.040
Why?
Mice
4
1994
10294
0.040
Why?
Cell Line
2
2001
1983
0.040
Why?
Neurologic Examination
1
2019
52
0.040
Why?
Hemiplegia
1
1998
4
0.040
Why?
CD4-Positive T-Lymphocytes
2
2000
623
0.040
Why?
Administration, Oral
1
2019
355
0.040
Why?
Radiography
1
2019
516
0.040
Why?
Influenza Vaccines
1
1998
91
0.040
Why?
Triage
1
2017
108
0.030
Why?
Dementia, Multi-Infarct
1
1996
4
0.030
Why?
Brain Abscess
1
1996
7
0.030
Why?
Child
3
1991
4187
0.030
Why?
Zalcitabine
1
1996
2
0.030
Why?
Stavudine
1
1996
3
0.030
Why?
Linear Models
1
2017
403
0.030
Why?
Naphthalenesulfonates
1
1996
1
0.030
Why?
Fatal Outcome
1
1996
116
0.030
Why?
Reverse Transcriptase Inhibitors
1
1996
28
0.030
Why?
RNA, Messenger
1
2001
1465
0.030
Why?
Evoked Potentials, Auditory
1
1995
10
0.030
Why?
Dementia, Vascular
1
1995
7
0.030
Why?
CD8-Positive T-Lymphocytes
1
2000
651
0.030
Why?
Disease Models, Animal
2
1993
2053
0.030
Why?
Patient Admission
1
2017
184
0.030
Why?
Chi-Square Distribution
1
2016
409
0.030
Why?
Patient Transfer
1
2016
90
0.030
Why?
CD4 Antigens
1
1996
148
0.030
Why?
Disability Evaluation
1
2016
199
0.030
Why?
HIV Envelope Protein gp120
1
1996
130
0.030
Why?
Cost of Illness
1
2015
156
0.030
Why?
Massachusetts
1
2020
2019
0.030
Why?
Emergency Medical Services
1
2017
255
0.030
Why?
Virulence
1
1994
188
0.030
Why?
Intensive Care Units
1
2017
423
0.030
Why?
ROC Curve
1
2014
267
0.030
Why?
Colony Count, Microbial
1
1993
57
0.030
Why?
Registries
1
2016
799
0.030
Why?
Endocytosis
1
1992
149
0.020
Why?
Image Processing, Computer-Assisted
1
2014
651
0.020
Why?
Paresthesia
1
1989
5
0.020
Why?
Neurons, Afferent
1
1989
17
0.020
Why?
Electroretinography
1
1989
26
0.020
Why?
Neural Conduction
1
1989
29
0.020
Why?
Electrophysiology
1
1989
87
0.020
Why?
Intraocular Pressure
1
1989
59
0.020
Why?
Cell Membrane
1
1992
486
0.020
Why?
Receptors, Cell Surface
1
1992
428
0.020
Why?
Hydroxycholesterols
1
2009
8
0.020
Why?
Heptanoic Acids
1
2009
20
0.020
Why?
Glaucoma
1
1989
46
0.020
Why?
Simvastatin
1
2009
26
0.020
Why?
Disease Outbreaks
1
1989
102
0.020
Why?
Pyrroles
1
2009
45
0.020
Why?
Apolipoproteins E
1
2009
108
0.020
Why?
Parathyroid Glands
1
1988
8
0.020
Why?
Motor Neurons
1
1989
203
0.020
Why?
United States
2
2015
7426
0.020
Why?
Apolipoprotein E4
1
2007
44
0.020
Why?
Preoperative Care
1
1988
180
0.020
Why?
Vitamin D
1
1988
131
0.020
Why?
Papilledema
1
1987
10
0.020
Why?
Retinitis Pigmentosa
1
1987
28
0.020
Why?
Positron-Emission Tomography
1
2007
200
0.020
Why?
Pilot Projects
1
2009
914
0.020
Why?
Calcium
1
1988
555
0.010
Why?
Tennessee
1
2003
16
0.010
Why?
Viral Load
1
2000
220
0.010
Why?
Immunity, Cellular
1
2000
171
0.010
Why?
Adolescent
1
1989
5835
0.010
Why?
Anti-HIV Agents
1
2000
153
0.010
Why?
Encephalomyelitis
1
1998
5
0.010
Why?
Medicare
1
2003
601
0.010
Why?
Interferon-gamma
1
2000
551
0.010
Why?
Longitudinal Studies
1
2000
1189
0.010
Why?
Lamivudine
1
1996
7
0.010
Why?
HIV Reverse Transcriptase
1
1996
10
0.010
Why?
Macaca fascicularis
1
1996
46
0.010
Why?
Cell Line, Transformed
1
1996
98
0.010
Why?
Binding, Competitive
1
1996
98
0.010
Why?
RNA-Directed DNA Polymerase
1
1996
34
0.010
Why?
Drug Synergism
1
1996
132
0.010
Why?
HIV Seropositivity
1
1996
82
0.010
Why?
In Vitro Techniques
1
1994
471
0.010
Why?
Polymerase Chain Reaction
1
1994
495
0.010
Why?
Polymers
1
1996
316
0.010
Why?
Rats
1
1996
1910
0.010
Why?
Monocytes
1
1994
345
0.010
Why?
Protein Binding
1
1996
1555
0.010
Why?
Foot Deformities, Congenital
1
1987
2
0.000
Why?
Hand Deformities, Congenital
1
1987
2
0.000
Why?
Blindness
1
1987
38
0.000
Why?
Fluorescein Angiography
1
1987
57
0.000
Why?
Syndrome
1
1987
170
0.000
Why?
Moonis's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (316)
Explore
_
Co-Authors (26)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_